The CHMP recommended extending the indications for olezarsen in the EU to causes of severe hypertriglyceridemia other than ...
Preemptive donor lymphocyte infusion (DLI) before HSCT yields superior outcomes compared with therapeutic DLI in patients with MDS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results